logo
logo
Sign in

Treatment for Dravet Syndrome depends on a number of factors, including the type of seizures and the child's age

avatar
CMI Blogging
Treatment for Dravet Syndrome depends on a number of factors, including the type of seizures and the child's age

Although there is no treatment for Dravet syndrome, anti-seizure medicines such as valproic acid (Depakote, Depakene), clobazam (Onfi, Frisium), topiramate (Topamax), stiripentol (Diacomit), and the ketogenic diet are used to reduce seizures. Dravet syndrome is a rare, severe, and life-long epileptic disease (seizure disorder). Mutations in a gene required for brain cell activation cause it. It is a severe and progressive genetic epilepsy characterized by frequent, prolonged, and refractory seizures that frequently begin in the first year of life. As a result, there is a rising need for Dravet syndrome therapy that is both safe and effective.

 

Recent studies suggest that genetic factors and neurological anomalies may play a major role in the development of this disease. The risk of death in patients with Dravet syndrome is higher due to complications such as organ failure, cardiac arrest, seizures, or comatose condition. Many epileptic patients are misdiagnosed, but more are being treated effectively despite misdiagnosis. People with severe forms of cerebral palsy and other kinds of epilepsy may be able to improve their outcomes due to advances in treatment. It is possible to confirm the diagnosis with a blood test for the mutation.

 

Patients with Dravet syndrome have a variety of therapeutic choices for enhancing their quality of life and managing their seizures. The condition is decreased by reducing the severity of Dravet syndrome, increasing brain function, slowing neuron degradation, and lowering the likelihood of future seizures. Dravet syndrome therapy aims to reduce seizure frequency and intensity, enhance seizure sensitivity, boost motivation and alertness, avoid brain cell destruction, lower muscular tone and strength, and increase social contact. Antiepileptic drugs are those used to treat epilepsy. These medicines must be taken as part of the Dravet syndrome treatment regimen.

Furthermore, Dravet syndrome therapy focuses on addressing the underlying pathology of the disorder as well as preventing or minimizing the disease's negative side effects. Seizures can be fatal in young children and can worsen as they grow older. This disorder can lead to death in rare cases. Convulsions can occur with varying frequency from one patient to the next, and they can be extremely light for some people while being more regular for others. Convulsions may occur more frequently at night, or they may occur at random. The treatment also aims to reduce the frequency of such episodes so that they do not disrupt everyday activities.

 

In order to prevent Dravet syndrome from recurring, proper medication is needed. Dravet syndrome, however, can cause severe disabilities and make living a challenge. Children with epilepsy are also more likely to die suddenly from unidentified causes than children with other types of epilepsy. Dravet syndrome is treated primarily with clobazam and valproate, although topiramate and stiripentol may also be prescribed. Dravet syndrome is best treated by a specialist epilepsy doctor, and often requires three types of anti-epileptic medicine to control symptoms.

collect
0
avatar
CMI Blogging
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more